and vaccine

For decades, the Epstein-Barr Virus (EBV) – the cause of infectious mononucleosis, or “mono” – has been a ubiquitous, largely unaddressed global health concern. Now, recent breakthroughs in vaccine development offer a potentially transformative shift in how we combat this incredibly common virus, which infects approximately 95% of the world’s population and is increasingly linked … Read more